The Effects of Arixtra on Wound Drainage Following Total Joint Arthroplasty

Completed · Phase 4

Conditions studied: Total Knee Replacement

In brief

The investigators hypothesize that Arixtra patients will be less likely to experience wound infection than patients who have received low-molecular weight heparin, coumadin or aspirin with mechanical compression.

Key facts

Study ID

NCT00909064

Run by

Paul Di Cesare,MD

People needed

114

Starts

2009-06-01

Expected to finish

2009-12-01

Last updated by the study team

2017-05-15

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• All primary unilateral TKA and THA cases will be included.

You may not qualify if…

• Patients less than 50 kg, Patients with CrCl<30ml/min. Revision and bilateral procedures will be excluded.

Where it is running

• U C Davis — Sacramento, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.